New aspects of the pathogenesis of lateral amyotrophic sclerosis

Close metadata

Recommended articles:

Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21

Cognitive impairment in multiple system atrophy — exclusion criteria or an integral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91

B vitamins and diseases of the peripheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82

Amyotrophic lateral sclerosis associated with a new pathogenic variant of the ERBB4 gene. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):165-168

Molecular Genetic Aspects of Varicose Vein Disease: Modern Concepts. Journal of Venous Disorders. 2024;(1):48-53

Genetic factors in degenerative disc disease. Burdenko's Journal of Neurosurgery. 2024;(2):112-118

Pathogenetic, clinical-diagnostic and therapeutic aspects of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42

Morphological features of vasoproliferative tumor of the retina. Russian Journal of Archive of Pathology. 2024;(2):42-50

Role of superoxide dismutase in acute pancreatitis: from antioxidant protection to gene regulation. Pirogov Russian Journal of Surgery. 2024;(4):112-117

Clinical and morphological assessment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135

Keywords:

amyotrophic lateral sclerosis

pathogenesis

anomaly protein aggregation

proteinopathy

superoxide dismutase

TDP-43

FUS

Authors:

Skvortsova V.I.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet;
NII tserebrovaskuliarnoĭ patologii i insul'ta, Moskva

Bachurin S.O.

Razinskaia O.D.

Smirnov A.P.

Kovrazhkina E.A.

Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet;
NII tserebrovaskuliarnoĭ patologii i insul'ta, Moskva

Pochigaeva K.I.

Moscow Research and Clinical Center for Neuropsychiatry

Ninkina N.N.

Shelkovnikova T.A.

Ustiugov A.A.

List of references:

Egorkina O.V., Voloshina N.P., Gaponov I.K. Bokovoi amiotroficheskii skleroz: osnovnye sovremennye napravleniya v lechenii. Mezhdunarodnyi nevrologicheskii zhurnal 2008; 6: 22.
Islamov R.R., Rizvanov A.A., Kiyasov A.P. Bokovoi amiotroficheskii skleroz: strategiya genno-kletochnoi terapii. Nevr vestn 2008; T-XL: 4: 91-100.
Skvortsova V.I., Limborskaya S.A., Levitskii G.N. Sovremennye predstavleniya ob etiologii, patogeneze i lechenii bolezni dvigatel'nogo neirona. Zhurn nevrol i psikhiat 2005; 1.
Al-Chalabi A., Andersen P.M., Nilsson P. et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet 1999; 8: 2: 157-164.
Al-Chalabi A., Hansen V.K., Simpson C.L. et al. Variants in the ALS2 gene are not associated with sporadic amyotrophic lateral sclerosis. J Neurogenetics 2003; 4: 4: 221-222.
Anand P., Parrett A., Martin J. et al. Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat Med 1995; 1: 168-172.
Appel S. ALS: immune factors in motor neuron cell injury. Neurobiology of ALS: education program syllabus. Minneapolis: American Academy of Neurology 1999; 101-113.
Arai T., Hasegawa M., Akiyama H. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 3: 602-611. Epub 2006 Oct 30.
Banks G.T., Kuta A., Isaacs A.M., Fisher E.M. TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander. Mamm Genome 2008; 19: 5: 299-230.
Bernreuther C., Diche M., Johann V. et al. Neural cell adhesion molecule L1-trancfected embrionic stem cells promote functional recovery after exsitoxic lession of the mouse striatum. J Neurosci 2006; 26: 45: 11532-11539.
Bruns C.K., Kopito R.R. Impaired post-translational folding of familial ALS-linked Cu, Zn superoxide dismutase mutants. EMBO J 2007; 26: 3: 855-866.
Buratti E., Baralle F.E. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 2008; 13: 867-878.
Sapano C.P., Pernas-Alonso R., Porzio U. Neurofilament homeostasis and motoneurone degeneration. BioEssays 2001; 23: 24-33.
Chen H.K., Bernreuther C., Diche M., Sanberg M. Cell adhesion molecule 11-transferred embrionic stem cells with enharced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma 2005; 22: 8: 896-906.
Chen R., Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 2000; 31: 1-2: 21-30.
Corbo M., Lunetta C., Magni P. et al. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients. Eur J Neurol 2009.
Corrado L., Ratti A., Gellera C. et al. High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis 2009; 30: 4: 688-694.
Cummings J.L. Neurological progress toward a molecular neuropsychiatry of neurodegenerative diseases. Ann Neurol 2003; 54: 2.
Di Lazzaro V., Pilato F., Profice P. et al. Motor cortex stimulation for ALS: a double blind placebo-controlled study. Neurosci Lett 2009; 16: 464: 1: 18-21.
Geser F., Brandmeir N.J., Kwong L.K. et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 5: 636-641.
Gitcho M.A., Baloh R.H., Chakraverty S. et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008; 63: 4: 535-538.
Green S.L., Tolwani R.J., Varma S. et al. Structure, chromosomal location, and analysis of the canine Cu/Zn superoxide dismutase (SOD1) gene. J Hered 2002; 93: 2: 119-124.
Grierson A.J., Miller C. Axonal transport and amyotrophic lateral sclerosis. In: Amyotrophic Lateral Sclerosis 2nd edition. Edited by Jr.R.H. Brown, M. Swash, P. Pasinelli. Inform Healthcare 2006; 309-318.
Guegan C., Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J Clin Invest 2003; 111: 153-161.
Hafezparast M., Ahmad-Annuar A., Hummerich H. et al. Paradigms for the identification of new genes in motor neuron degeneration. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 4: 249-257.
Henkel J.S., Engelhardt J.I., Siklos L. et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004; 55: 221-235.
Jablonka S., Wiese S., Sendtner M. Axonal defects in mouse models of motoneuron disease. J Neurobiol 2004; 5: 58: 2: 272-286.
Kabashi E., Valdmanis P.N., Dion P. et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008; 40: 5: 572-574. Epub 2008 Mar 30.
Kim Y.J., Nakatomi R., Akagi T. et al. Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutants. J Biol Chem 2005; 280: 22: 21515-21521.
Kirby J., Goodall E.F., Smith W. et al. Broad clinical phenotypes associated with TAR-DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. Neurogenetics 2009.
Koichi Okamoto Y.M., Yukio Fujita Bunina bodies in amyotrophic lateral sclerosis. Neuropathology 2008; 28: 109-115.
Krasnianski A., Deschauer M., Neudecker S. et al. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies. Brain 2005; 128: 1870-1876.
Kwiatkowski T.J.Jr., Bosco D.A., Leclerc A.L. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 27: 323: 5918: 1205-1208.
Lee J., Ryu H., Kowall N.W. Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. Biochem Biophys Res Commun 2009; 10: 384: 4: 524-529.
Leigh P.N., Swash M. Motor neuron disease. Springler-Verlag, London 1995; 467.
Manetto V., Sternberger N.H., Perry G. et al. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1988; 47: 642-665.
Manfredi G., Xu Z. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 2005; 5: 2: 77-87.
McCluskey L.F., Elman L.B., Martinez-Lage M. et al. Amyotrophic Lateral Sclerosis-Plus Syndrome With TAR DNA-Binding Protein-43 Pathology. Arch Neurol 2009; 66: 1: 121-124.
Miller R.G., Mitchell J.D., Lyon M., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007; 24: 1: CD001447.
Neumann M. Molecular neuropathology of TDP-43 proteinopathies. Int J Mol Sci 2009; 10: 1: 232-246. Epub 2009 Jan 9.
Neumann M., Sampathu D.M., Kwong L.K. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 5796: 130-133.
Oosthuyse B., Moons L., Storkebaum E. et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131-138.
Pamela J., Shaw P.G.I., Falkous G., Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695.
Piao Y.S., Wakabayashi K., Kakita A. et al. Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003; 13: 10-22.
Puls I., Jonnakuty C., LaMonte B.H. et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455-456.
Ralph G.S., Binley K., Wong L.F. Gene therapy for neurodegenerative and ocular didease using lentiviral vectors. Clin Sci 2006; 110: 1: 37-46.
Ralph G.S., Radcliffe P.A., Day D.M. et al. Silencing mutanr SOD1 using RNAi protects against neurodegeneration and extend survival in an ALS model. Nat Med 2005; 11: 4: 429-433.
Raoul C., Abbas-Terki T., Bensadoun J.C. et al. Lentiviral-mediated silensing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 2005; 11: 4: 423-428.
Rosen D.R., Siddique T., Patterson D. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
Shaw C.E., Al-Chalabi A., Leigh N. Progress in the pathogenesis of amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 2001; 1: 1: 69-76.
Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiat 2005; 76: 1046-1057.
Shaw P.J., Forrest V., Ince P.G. et al. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 1995; 4: 209-216.
Shi P., Gal J., Kwinter D.M. et al. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta 2009; 26.
Sreedharan J., Blair I.P., Tripathi V.B. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 21: 319: 5870: 1668-1672.
Tan C.F., Eguchi H., Tagawa A. et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol (Berl) 2007; 113: 535-542.
Toyoshima I., Sugawara M., Kato K. et al. Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease. J Neurol Sci 1998; 159: 1: 38-44.
Tu P.H., Raju P., Robinson K.A. et. al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci USA 1996; 93: 3155-3160.
Van Landeghem G.F., Tabatabaie P., Beckman G. et al. Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease. Eur J Neurol 1999; 6: 6: 639-644.
Vance C., Rogelj B., Hortobágyi T. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 5918: 1208-1211.
Weissmann C., Brandt R. Mechanisms of neurodegenerative diseases: insights from live cell imaging. J Neurosci Res 2008; 15: 86: 3: 504-511.
Yamanaka K., Vande Velde C., Eymard-Pierre E. et al. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc Natl Acad Sci USA 2003; 100: 26: 16041-16046.

Close metadata